Therefore, the EULAR Task Force on COVID-19 has updated the EULAR View-points on SARS-CoV-2 vaccination in patients with RMDs (December 2021) to address these questions, including considerations regarding vaccination effectiveness and safety, the third vaccination dose, booster vaccination, combination with Influenza and Pneumococcus vaccination, among other frequently asked questions by people with RMDs. We invite all of you to share the link with your own organisation and network: put it on your own website, translate the content, mail it to your members.
https://www.eular.org/eular_sars_cov_2_vaccination_rmd...
Prof Annamaria Iagnocco
EULAR President
EULAR oppdatering om koronavaksine desember 2021
EULAR har publisert oppdateringer om vaksinasjon for pasienter med kronisk autoimmune og inflammatoriske sykdommer.